Supplements Containing Cannabidiol (CBD)
February 25th, 2016
The FDA also said in its letters that many of supplements were found to contain levels of CBD inconsistent with amounts advertised. And the agency cited a bevy of unapproved drug claims across all product websites, including claims to treat depression, heart disease, anxiety, schizophrenia, and cancer (several of these claims have since been removed).
Last February, the FDA issued similar warnings to six other CBD companies, including Canna-Pet, which advertised “hemp based help without the high” for cats and dogs. (Read our ad alert on Canna-Pet here.)
While the FDA prohibits supplements from containing cannabidiol, the agency acknowledges that several states are looking into allowing access to CBD in efforts to treat childhood epilepsy. But it adds, “It is important to conduct medical research into the safety and effectiveness of marijuana products through adequate and well-controlled clinical trials.”
Find more of our coverage on marijuana here.